Active Surveillance Deemed “Justifiable” Option for Metastatic Renal Cell Carcinoma
For real-world patients with mRCC, active surveillance may be a worthwhile alternative to immediate systemic therapy.
Christina Bennett, MS
Christina Bennett, MS, is an independent medical journalist based in New Mexico. She is a member of the Association of Healthcare Journalists and the National Association of Science Writers and was one of a dozen journalists selected for the 2017 National Cancer Reporting Fellowships. She writes about a variety of medical topics, including oncology, healthcare policy, and cell and gene therapies.
